THE POWER OF SHARED PURPOSE: TRANSFORMING GYNECOLOGIC CANCER CARE This year’s meeting theme is“The Power of Shared Purpose: Transforming Gynecologic Cancer Care”. 2024 Key Concepts include: Moving the Needle Together in Clinical Trials All In: Diversity and Inclusion Through Many Lenses Working To...
Clinical Trials, Medical Oncology Sandip Patel, MD UC San Diego, San Diego, California Developmental Therapeutics Mitchell C. Posner, MD The University of Chicago Medicine, Chicago, Illinois Gastrointestinal Disease Camille Ragin, PhD, MPH Fox Chase Cancer Center, Philadelphia, Pennsylvania ...
SAN DIEGO — The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than reported in prior clinical trials, according to study results. January 22, 2025 3 min read Save Mushroom supplement may slow prostate cancer...
The next phase of ICGC, ICGC-ARGO (https:// www.icgc-argo.org/), will bring the cancer genomics community together with healthcare providers, pharmaceutical companies, data science and clinical trials groups to build comprehensive knowledge banks of clinical outcome and treatment data from patients...
University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States Bladder cancer, Prostate cancer, Kidney cancer, Clinical trials, antibody drug conjugates Dr. Manigreeva Krishnatreya, MD Dr Bhubaneswar Borooah Cancer Institute, Guwahati, India...
Souvick Roy, PhD, Moores Cancer Center, University of California San Diego, USA Juan Ruiz Bañobre, MD ,PhD, University Clinical Hospital of Santiago de Compostela, Spain Andrea Ruzzenente, University of Verona, Italy Annamaria Ruzzo, PhD, University of Urbino, Italy Maja Sabol, PhD, Ruđer...
Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs JAMA Original Investigation June 25, 2024 This systematic review and meta-analysis examines whether patient participation in cancer trials is associated with greater survival benefit compared with routine care. ...
Clinical trials have also confirmed that reducing Bcl-2 expression can effectively improve the therapeutic outcomes of chemotherapy drugs such as paclitaxel or carboplatin in lung cancer [39]. Thus, the anti-lung cancer effect of EEFS through targeting Bcl-2 is worthy of further study. Third, ...
Additional Contributions: We gratefully acknowledge the following individuals for their contributions to this project: Tina Fan, MD, MPH (AHRQ); current and former members of the USPSTF who contributed to topic deliberations; Samir Gupta, MD, MSCS (University of California, San Diego), and Carolyn...
Clinical trials of antiangiogenic drugs: opportunities, problems, and assessment of initial results. J Clin Oncol : official journal of the American Society of Clinical Oncology. 2001;19(18 Suppl):45S–51S. CAS Google Scholar Saif MW. Anti-angiogenesis therapy in pancreatic carcinoma. JOP : ...